RA Capital Management - XILIO THERAPEUTICS INC ownership

XILIO THERAPEUTICS INC's ticker is and the CUSIP is 98422T100. A total of 30 filers reported holding XILIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
RA Capital Management ownership history of XILIO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$4,817,000
-66.0%
1,649,711
-17.6%
0.13%
-58.6%
Q1 2022$14,156,000
-55.8%
2,002,2170.0%0.31%
-45.3%
Q4 2021$32,035,0002,002,2170.56%
Other shareholders
XILIO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RiverVest Venture Management LLC 1,441,444$3,041,4477.52%
Trustees of Columbia University in the City of New York 249,635$526,7300.97%
Atlas Venture Life Science Advisors, LLC 2,759,344$5,822,2160.90%
Octagon Capital Advisors LP 2,318,500$4,892,0350.75%
Bain Capital Life Sciences Investors, LLC 2,805,413$5,919,4210.66%
HARVARD MANAGEMENT CO INC 416,059$8780.10%
Rock Springs Capital Management LP 1,440,759$3,040,0010.08%
Soleus Capital Management, L.P. 226,941$478,8460.04%
Artal Group S.A. 450,000$9500.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 110,481$233,1150.01%
View complete list of XILIO THERAPEUTICS INC shareholders